JP7897794B2 - 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム - Google Patents

循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム

Info

Publication number
JP7897794B2
JP7897794B2 JP2022538934A JP2022538934A JP7897794B2 JP 7897794 B2 JP7897794 B2 JP 7897794B2 JP 2022538934 A JP2022538934 A JP 2022538934A JP 2022538934 A JP2022538934 A JP 2022538934A JP 7897794 B2 JP7897794 B2 JP 7897794B2
Authority
JP
Japan
Prior art keywords
tumor
subject
methylation
cancer
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022538934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508947A5 (cg-RX-API-DMAC7.html
JP2023508947A (ja
Inventor
アレックス ロバートソン,
ニール ピーターマン,
ニコル ランバート,
ハルク テツカン,
ロヒト スリヴァス,
ピーター ジョージ,
ジェイソン クロース,
Original Assignee
レクセント バイオ, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by レクセント バイオ, インコーポレイテッド filed Critical レクセント バイオ, インコーポレイテッド
Publication of JP2023508947A publication Critical patent/JP2023508947A/ja
Publication of JP2023508947A5 publication Critical patent/JP2023508947A5/ja
Priority to JP2025188196A priority Critical patent/JP2026049725A/ja
Application granted granted Critical
Publication of JP7897794B2 publication Critical patent/JP7897794B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022538934A 2019-12-24 2020-12-23 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム Active JP7897794B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025188196A JP2026049725A (ja) 2019-12-24 2025-11-07 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962953368P 2019-12-24 2019-12-24
US62/953,368 2019-12-24
US202062993564P 2020-03-23 2020-03-23
US62/993,564 2020-03-23
PCT/US2020/066976 WO2021133993A2 (en) 2019-12-24 2020-12-23 Methods and systems for molecular disease assessment via analysis of circulating tumor dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025188196A Division JP2026049725A (ja) 2019-12-24 2025-11-07 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム

Publications (3)

Publication Number Publication Date
JP2023508947A JP2023508947A (ja) 2023-03-06
JP2023508947A5 JP2023508947A5 (cg-RX-API-DMAC7.html) 2023-12-25
JP7897794B2 true JP7897794B2 (ja) 2026-07-30

Family

ID=76575344

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022538934A Active JP7897794B2 (ja) 2019-12-24 2020-12-23 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム
JP2025188196A Pending JP2026049725A (ja) 2019-12-24 2025-11-07 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025188196A Pending JP2026049725A (ja) 2019-12-24 2025-11-07 循環腫瘍dnaの分析を介した分子疾患評価のための方法およびシステム

Country Status (8)

Country Link
US (1) US20230135171A1 (cg-RX-API-DMAC7.html)
EP (1) EP4081665A4 (cg-RX-API-DMAC7.html)
JP (2) JP7897794B2 (cg-RX-API-DMAC7.html)
CN (1) CN115087749A (cg-RX-API-DMAC7.html)
AU (1) AU2020414737A1 (cg-RX-API-DMAC7.html)
CA (1) CA3165763A1 (cg-RX-API-DMAC7.html)
TW (1) TWI893039B (cg-RX-API-DMAC7.html)
WO (1) WO2021133993A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11078475B2 (en) 2016-05-03 2021-08-03 Sinai Health System Methods of capturing cell-free methylated DNA and uses of same
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
CN118234871A (zh) * 2021-07-27 2024-06-21 牛津大学校长、教师和学者 与用于细胞游离dna的tet辅助吡啶硼烷测序相关的组合物和方法
US20230092508A1 (en) * 2021-09-20 2023-03-23 Droplet Biosciences, Inc. Methods for disease assessment using drain fluid
WO2023092097A1 (en) * 2021-11-19 2023-05-25 Foundation Medicine, Inc. Fragment consensus methods for ultrasensitive detection of aberrant methylation
CN114703284A (zh) * 2022-04-15 2022-07-05 北京莱盟君泰国际医疗技术开发有限公司 一种血液游离dna甲基化定量检测方法及其应用
KR102789317B1 (ko) * 2023-10-06 2025-04-02 (주)지놈포미 고심도 세포 유리 핵산 시퀀싱 기반의 질병 조기 검출 장치 및 방법
EP4790149A1 (en) * 2023-10-06 2026-08-12 Genome4Me, Inc. Apparatus and method for early disease detection based on high-depth cell-free nucleic acid sequencing
CN117987556B (zh) * 2024-02-23 2026-07-14 上海小荷医学检验实验室有限公司 用于确定肿瘤组织的目标CpG位点的甲基化水平的方法
CN118448038B (zh) * 2024-04-26 2026-07-24 天津大学 一种基于多组学动态ctDNA监测食管鳞状细胞癌疗效的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160017419A1 (en) 2014-07-18 2016-01-21 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in a dna mixture
WO2018161031A1 (en) 2017-03-02 2018-09-07 Youhealth Biotech, Limited Methylation markers for diagnosing hepatocellular carcinoma and lung cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019521673A (ja) * 2016-06-07 2019-08-08 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 疾患および状態の分析のためのセルフリーdnaメチル化パターン
CA3049457C (en) * 2017-01-20 2023-05-16 Sequenom, Inc. Methods for non-invasive assessment of copy number alterations
EP3776555A2 (en) * 2018-04-13 2021-02-17 Grail, Inc. Multi-assay prediction model for cancer detection
WO2019200410A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
CA3101527A1 (en) * 2018-06-06 2019-12-12 Lexent Bio, Inc. Methods for fingerprinting of biological samples

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160017419A1 (en) 2014-07-18 2016-01-21 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in a dna mixture
WO2018161031A1 (en) 2017-03-02 2018-09-07 Youhealth Biotech, Limited Methylation markers for diagnosing hepatocellular carcinoma and lung cancer

Also Published As

Publication number Publication date
JP2026049725A (ja) 2026-03-18
WO2021133993A2 (en) 2021-07-01
JP2023508947A (ja) 2023-03-06
TW202138566A (zh) 2021-10-16
AU2020414737A1 (en) 2022-07-14
US20230135171A1 (en) 2023-05-04
CN115087749A (zh) 2022-09-20
TWI893039B (zh) 2025-08-11
CA3165763A1 (en) 2021-07-01
WO2021133993A3 (en) 2021-09-30
EP4081665A2 (en) 2022-11-02
EP4081665A4 (en) 2024-01-10

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260601

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260713

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260717

R150 Certificate of patent or registration of utility model

Ref document number: 7897794

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150